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Haemorrhage following major injury remains the most
common potentially preventable cause of traumatic death
with exsanguination typically occurring within three
hours of injury. Key to improving outcomes is a “care
bundle” of measures to facilitate early diagnosis, rapid
haemorrhage control, systemic and topical haemostatic
support and short scene times [1]. The last decade has
seen a paradigm shift in treatment strategies and transfu-
sion algorithms [2] with an emphasis on haemostatic or
damage control resuscitation (DCR). A key objective of
this proactive and empiric approach to transfusion is to
directly target Acute Traumatic Coagulopathy (ATC)
which itself is associated with a four-fold increase in
mortality and poor patient outcomes. This article will
focus only on advanced interventions without further dis-
cussion of the fundamentals of pre-hospital haemorrhage
control i.e. oxygenation, intravenous or intra-osseous
assess, pelvic and limb splints and splinting of the facial
skeleton.
Identification of major haemorrhage must be performed
as part of the initial on-scene assessment. Good clinical
acumen and a high index of suspicion remain important
diagnostic tools. Point of care measures of coagulation are
of limited value in patients with major haemorrhage (low
haematocrit). The utility of these handheld devices, in
their current design, is confined to patients taking warfarin
who have suspected traumatic brain injury and where
reversal with prothrombin complex concentrate is indi-
cated. Pre-hospital use of ultrasound, solely for diagnostic
purposes, remains an area of controversy. Critiques argue
it adds little additional information and may delay transfer
to hospital for definitive haemorrhage control.
An immediate priority is to localise any sites of exter-
nal haemorrhage and provide direct control where pos-
sible with compression. Foley catheters inserted into a
wound track, inflated and then retracted to the skin
edge are good adjuncts for junctional injuries e.g. neck
stab wound. Topical haemostatic dressings e.g. Celox
impregnated gauze or granules are able to augment clot
formation and can be applied into cavities where hae-
morrhage may be difficult to control directly. The use of
limb tourniquets is now well established in combat
medicine and has been shown to save lives particularly
when applied before the onset of shock. Complications
i.e. nerve damage are rare when tourniquets are applied
correctly. The Eastern Association for the Surgery of
Trauma (EAST) has recently published guidelines advo-
cating their use in civilian patients for the management
of penetrating lower extremity arterial trauma [3].
Radical interventions for control of life-threating hae-
morrhage include prehospital thoracotomy (PHT) for
cardiac tamponade and (theoretically) resuscitative endo-
vascular balloon occlusion of the aorta (REBOA) for
major torso bleeding. PHT for penetrating trauma is an
established intervention in a physician-led EMS system
and is associated with survival rates of 18% in selected
patient groups. Relief of tamponade with control of car-
diac injury is the primary objective of PHT and can be
achieved with minimal equipment – scalpel, Spencer
Wells forceps, heavy scissors or Gigli saw, rib retractor
and sutures or skin stapler. During PHT other man-
oeuvres such as manual compression (or clamping) of
the descending aorta to arrest abdominopelvic haemor-
rhage and control of lung hila to treat great vessel inju-
ries may be of benefit but all efforts should be focused on
rapid transit to hospital for definitive surgical manage-
ment. REBOA describes the insertion of an endovascular
balloon into the femoral artery (under ultrasonic gui-
dance) which is advanced into the aorta and then inflated
to control distal haemorrhage. It has been successfully
used in the Emergency Department (ED) with and with-
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interest [4]. Although feasible in pre-hospital care it
remains subject to proof of concept evaluation although
has a potentially important role in the pre-hospital man-
agement of major pelvic injuries. Balloon occlusion at the
level of the aortic bifurcation can be achieved without
the use of fluroscopy and could theoretically control cata-
strophic pelvic bleeding.
Direct control of haemorrhage must be accompanied
with DCR - permissive hypotension, resuscitation and
haemostatic support with pro-coagulant blood products.
The efficacy of high dose blood component therapy and
optimal plasma:red blood cell (RBC) ratio is currently
unknown. However, the PROPPR trial (http://cetir-tmc.
org/research/proppr) is the first randomised controlled
trial (RCT) to investigate blood product ratios in trauma
and is due to report in early 2014. Combat pre-hospital
systems utilise both RBC and thawed fresh frozen
plasma (FFP) but due to the logistical challenges of car-
rying these blood products the vast majority of civilian
EMS systems only utilise RBCs. Blood resuscitation of
the exsanguinating patient may be the preferable thera-
peutic option compared to crystalloids but its pre-hospi-
tal use must be supported with rapid availability of
plasma, platelets and fibrinogen on arrival in ED to
avoid the dilutional coagulopathy associated with large
volume RBC transfusion. Work is currently underway to
evaluate freeze dried plasma which has the advantage of
potential reconstitution at scene however the true effi-
cacy of any plasma formulation to correct ATC remains
to be seen.
Haemostasis is critically dependent on fibrinogen as a
substrate for clot formation and levels are known to
decrease both rapidly and significantly during massive
haemorrhage. Low fibrinogen levels are associated with
increased mortality and early fibrinogen supplementa-
tion (cryoprecipitate or concentrate) may improve
patient survival [5]. Early and high dose fibrinogen
replacement is the subject of two pilot RCTs in the UK
(CRYOSTAT - ED) and Austria (FiTIC – pre-hospital)
due to report later this year. Fibrinogen concentrate is
well-suited for use in austere environments and has the
potential to be the primary pro-coagulant agent for pre-
hospital DCR. All severely injured patients with bleeding
have profound activation of the fibrinolytic system. The
CRASH-2 trial has shown clear mortality benefits with
the early use of tranexamic acid (TXA) in trauma hae-
morrhage, which should be considered first line in all
patients with major bleeding.
Effective treatment of haemorrhage in the pre-hospital
phase of care is dependent on rapid identification of
severe bleeding, direct anatomical control of vascular
injury, haemostatic resuscitation and expedient transfer
to hospital. Tourniquets and topical haemostats are
important adjuncts for the control of junctional or
extremity injuries and augmentation of in vivo clotting
processes. PHT is a life-saving and established interven-
tion for cardiac tamponade and pre-hospital use of
REBOA may provide additional treatment options to con-
trol major torso haemorrhage. Replacement of oxygen-
carrying capacity with RBC, haemostatic resuscitation with
fibrinogen supplementation and treatment of fibrinolysis
with TXA are likely to prove important therapeutic agents
in the prehospital treatment of haemorrhage.
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